Immunovant, Inc. (IMVT) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Immunovant, Inc. (IMVT) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

IMVT Cash Flow Statement

Immunovant, Inc. (IMVT) cash flow statement — 9-year operating, investing & financing cash flows

Metric	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22

Cash from Operations	-124.41M	-95.06M	-92.33M	-102.52M	-117.41M	-110.64M	-100.39M	-88.65M	-76.2M	-59.7M	-47.1M	-60.06M	-47.37M	-55.79M	-46.4M	-20.19M	-65.82M	-32.96M	-31.89M	-20.05M
Operating CF Margin %	-1753.42%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-5.96%	14.08%	8.03%	-15.64%	-54.08%	-85.32%	-113.15%	-47.6%	-60.86%	-7%	-1.52%	-197.53%	28.03%	-69.3%	-45.46%	-0.69%	-210.26%	-46.5%	-39.8%	17.22%
Net Income	-153.22M	-147.86M	-110.64M	-126.5M	-120.61M	-106.45M	-111.12M	-109.12M	-87.15M	-75.32M	-51.42M	-58.66M	-73.94M	-59.43M	-63.23M	-47.93M	-40.37M	-47.17M	-41.38M	-37.7M
Depreciation & Amortization	119K	96K	101K	105K	107K	109K	99K	89K	80K	64K	58K	349K	343K	341K	333K	46K	323K	39K	33K	28K
Stock-Based Compensation	13.77M	11.14M	12.71M	13.36M	18.51M	11.69M	11.65M	12.69M	13.46M	9.68M	10.22M	0	0	0	0	8.16M	0	11.86M	10.16M	8.36M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	0	26K	25K	24K	24K	22K	23K	22K	66K	252K	295K	10.53M	10.69M	7.55M	8.91M	281K	7.69M	275K	-460K	446K
Working Capital Changes	14.93M	41.53M	5.47M	10.5M	-15.44M	-16.01M	-1.04M	7.67M	-2.65M	5.63M	-6.25M	-12.28M	15.54M	-4.25M	7.59M	19.26M	-33.46M	2.04M	-242K	8.82M
Change in Receivables	436K	-1.82M	319K	-25K	129K	-176K	-197K	417K	2.93M	-4.12M	266K	-561K	-142K	463K	2.94M	9.76M	-947K	0	-7.53M	-177K
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	2.6M	-1.35M	1.56M	-1.06M	-9.4M	-2.3M	-260K	9.37M	3.88M	3.39M	-3.7M	-18.91M	25.01M	-12.63M	6.47M	6.52M	-17.48M	14.87M	-427K	1.14M
Cash from Investing	0	-8K	0	0	0	-201K	-180K	-196K	-182K	-150K	-131K	-34K	-45K	-26K	-98K	-31K	-42K	-118K	-74K	-44K
Capital Expenditures	0	-8K	0	0	0	-201K	-180K	-196K	-182K	-150K	-131K	-34K	-45K	-26K	-98K	-31K	-42K	-118K	-74K	-44K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	20.1M	3.64M	564.6M	24.59M	2.92M	450.61M	2.46M	730K	686K	1.54M	469.84M	148K	890K	233K	70.63M	0	21K	0	0	200.04M
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	20.1M	3.56M	564.6M	24.59M	2.92M	450M	2.46M	730K	686K	474.29M	-2.9M	148K	890K	70.73M	131K	0	21K	0	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	82K	0	0	0	612K	0	0	0	-472.75M	472.75M	0	0	-70.5M	70.5M	0	0	0	0	200.04M
Net Change in Cash	-104.31M	-92.42M	472.65M	-77.04M	-115.06M	339.29M	-98.26M	-87.06M	-75.36M	-55.57M	421.01M	-60.03M	-46.57M	-56.08M	26.84M	-21.43M	-66.61M	-33.19M	-31.95M	179.95M
Free Cash Flow	-124.41M	-95.07M	-92.33M	-102.52M	-117.41M	-110.84M	-100.57M	-88.84M	-76.38M	-59.85M	-47.23M	-60.09M	-47.41M	-55.82M	-46.49M	-20.22M	-65.86M	-33.07M	-31.97M	-20.09M
FCF Margin %	-1753.42%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-5.96%	14.23%	8.2%	-15.39%	-53.72%	-85.2%	-112.94%	-47.84%	-61.09%	-7.22%	-1.58%	-197.24%	28.01%	-68.77%	-45.43%	-0.63%	-210.2%	-46.4%	-39.94%	17.17%
FCF per Share	-0.61	-0.47	-0.51	-0.59	-0.69	-0.73	-0.68	-0.61	-0.52	-0.41	-0.33	-0.46	-0.36	-0.43	-0.36	-0.17	-0.57	-0.28	-0.28	-0.18
FCF Conversion (FCF/Net Income)	0.81x	0.64x	0.83x	0.81x	0.97x	1.04x	0.90x	0.81x	0.87x	0.79x	0.92x	1.02x	0.64x	0.94x	0.73x	0.42x	1.63x	0.70x	0.77x	0.53x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	-51K	0	0	0	901K	0	0	0	0	0	0	0	0	0	0	0	0	0	0